At a small UK biotech bench, a reconstitution step is rarely just about adding diluent. It is a short, information-dense activity that links the batch certificate, the material in the vial, the in-vitro assay design and the colleague who will repeat the work next week. Good documentation makes that link visible and keeps the work inside a controlled laboratory workflow. Research-use-only materials are not for human or veterinary use, and the record should say so plainly.
Start with the batch, not the pipette
Batch identity and certificate check
Before a vial is opened, record its identity: product name, catalogue code, supplier, receipt record and label reference. For Research Sciences products, the label reference may combine SKU and expiry, such as BPC10-03/27; quote it exactly when asking about documentation. Record the batch CoA reference and any Internal Test Reference shown. Do not treat cap colour as an indicator of identity, analytical quality or manufacturing origin, because packaging may vary. The record should let a colleague find the same certificate without asking you.
Open the CoA that accompanies the specific batch. The shop states that CoAs are provided for every product, with HPLC purity and identity information, and that products are independently tested; the homepage also lists CoAs Janoshik Analytical Reports. Treat those as the supplier’s published wording and reconfirm the actual batch CoA before use. Record the certificate reference rather than a remembered headline figure. If the CoA is missing or unclear, pause the reconstitution and resolve it before the vial enters the workflow.
Document the diluent as carefully as the peptide. Catalogue wording such as 10ml Mixing Water or Bacteriostatic Water may appear, but the study record should state the exact diluent lot, volume, container and storage conditions specified by the local SOP and in-vitro assay design. Keep the supplier documents with the internal batch record. The materials remain research-use-only and are not for human or veterinary use.
Before a new catalogue item enters a study, review the current listing and Buy peptides only after checking the product page and batch CoA for the material in hand. The all-products page is a route into the catalogue, not a substitute for batch-level documentation. Record why the item was selected, who approved it and how it was stored on receipt.
Build a reconstitution record a colleague can follow
Volume, concentration and observations
Reconstitution should be written as a repeatable sequence, not a summary. Record when the vial was removed from storage and when it reached ambient temperature before opening, because the site’s handling guidance says to allow vials to reach room temperature first. Note the clean-environment conditions, the tools used and the amount removed for the experiment. If only part of the vial is required, record how the remainder was sealed, protected from light and moisture, and returned to storage according to local practice. Avoid repeated freeze–thaw cycles and record any temperature excursion.
The core entry should capture diluent volume, final volume and the resulting concentration for the in-vitro assay. For example, if a 5 mg lyophilised research peptide is brought to 2.5 mL with diluent, record the calculation and the resulting 2 mg/mL working concentration so a colleague can follow the arithmetic. If the supplier’s free peptide reconstitution calculator is used, record that it was used, the inputs entered, the output and the person who checked it. The calculator is for laboratory research only and must not be used for human or veterinary dosing. Mixing method should follow the local SOP; record what was done rather than what was intended.
Add observations that affect repetition: vial appearance before and after dilution, whether dissolution was complete, any visible particles, and any deviation from the SOP. If a filtration or transfer step is part of the approved method, record the device, lot and receiving container. Record the final label applied to the working stock: study ID, material, batch/CoA reference, concentration, diluent, storage condition and the preparer’s initials. For reconstituted material, the shop’s quick guide describes short-term laboratory storage at 2–8°C; follow that only as part of your local risk assessment and label the aliquot clearly. All materials are not for human or veterinary use.
Do not leave the calculation to memory. A colleague should be able to reconstruct the concentration from the recorded vial mass, diluent volume and final volume without guessing. If the study uses a dilution series, record the first working concentration and the dilution scheme so it can be checked independently. This matters on a small bench, where one person may prepare the material and another may run the assay.
Handover, version control and the audit trail
A handover sheet that survives the week
A handover is stronger when it is designed as an audit trail. Use a one-page handover sheet that lists the study ID, material, batch and CoA reference, label reference, diluent lot, final concentration, storage location, quantity remaining, deviations and the preparer. Attach or cross-reference the CoA, the SOP version and any calculator output. The next colleague should be able to repeat the step without relying on a verbal explanation. If the material is restocked, record the new label reference and check whether the site states that it carries the same ITR as earlier stock; an ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing.
Version control matters as much as the entry itself. Record the SOP version used, the operator’s training record and any approved change to the method. If packaging differs between deliveries, note the difference without assuming it changes identity or quality; cap colour and other packaging may vary. Keep supplier documentation, internal batch records and deviation reports together, and review the handover before the next run. For UK laboratories, align the record with COSHH assessments, local safety standards and disposal procedures. The purchaser is responsible for lawful use, safe handling, storage and disposal, and for confirming that the material is suitable for the intended in-vitro application.
A useful check is to ask a colleague who did not perform the step to read the record and explain how they would repeat it. If they cannot identify the batch, diluent, concentration, storage condition and deviation history, the record is incomplete. The shop describes its products as labelled “For Research Use Only – Not for Human Consumption” and as being in line with MHRA guidance; treat that as the supplier’s stated position and follow your own compliance review. The materials are not for human or veterinary use, and reconstitution must remain a controlled laboratory step for in-vitro research.
